Oura's $2B Revenue Run Rate Fuels $16B IPO Bid

For retail and e-commerce leaders, Oura's confidential SEC filing is more than another tech IPO—it is a live case study in premium direct-to-consumer hardware scaling. The company turned about 3 million ring sales over the past year into expected near-$2 billion revenue, and now plans to raise up to $3 billion as early as September 2026 to widen its market reach.

Finnish wearable maker Oura Health is reportedly preparing to enter public markets with an initial public offering that could raise as much as $3 billion and value the smart ring specialist around $16 billion. The disclosure, attributed to a Bloomberg report and syndicated across multiple iHeartMedia radio station websites on August 25, 2026, describes a confidential filing with the U.S. Securities and Exchange Commission and a listing that could begin as early as September 2026. Because Oura has not publicly confirmed the filing, the figures are best understood as reported targets rather than final IPO terms.

“

Oura reported $500 million in revenue in 2024, doubled that to $1 billion in 2025, and expects to approach $2 billion in 2026.

The growth trajectory is unusually steep for a consumer hardware brand. Oura reported $500 million in revenue in 2024, doubled that to $1 billion in 2025, and expects to approach $2 billion in 2026. That implies two consecutive years of roughly 100% top-line growth, a rare pattern in the hardware sector where annual product cycles and inventory constraints typically flatten expansion. The company also disclosed selling about 3 million rings over the past year, which, when viewed against the near-$2 billion revenue expectation, points to roughly $650 to $670 in revenue per ring sold. That blended average is likely a mix of hardware and the recurring membership/subscription revenue that has become central to Oura's model, and it underscores why public markets may reward the business with a software-like multiple rather than a traditional gadget maker's discount.

Valuation details suggest institutional investors have already priced a significant premium. A recent financing round raised $875 million at an approximate $11 billion valuation, roughly 11 times trailing 2025 revenue. The reported IPO target of $16 billion would represent a 45% step-up from that private round and about 8 times expected current-year revenue near $2 billion. If Oura sells $3 billion in new shares at that valuation, it would be offering roughly 18.75% of the company, excluding any overallotment option. The exact number of shares and price range have not been set, a reminder that confidential filings are often exploratory and can be revised or withdrawn depending on market conditions.